BS01 for retinitis pigmentosa

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 6 Feb 2020: Trial started, NCT04278131
  2. 20 Feb 2020: Trial registered, NCT04278131

The trials

NCT04278131: BS01 in Patients With Retinitis Pigmentosa

State
Under way
Phase
Phase 1 and Phase 2
People
20 planned
Started
6 Feb 2020
Primary completion
30 Dec 2026
Arms
Cohort 1, Cohort 2, Cohort 3, Cohort 4, Cohort 5, Cohort 6
Results
None posted
  1. 6 Feb 2020: Trial started
  2. 20 Feb 2020: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.